Benzinga | Aug 10, 2020 07:53AM EDT

Axsome Therapeutics Q2 EPS $(0.49) Beats $(0.62) Estimate

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.62) by 20.97 percent. This is a 19.51 percent decrease over losses of $(0.41) per share from the same period last year.